Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of ...

Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing ...

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic ...

The Connecticut Medical Examining Board agreed to add a year to the probation of a Stamford physician whose license to ...

A survey of Scripps Health clinicians reveals that specialty and personal risk assessment of side effects drive the chronic cough treatment gap.

A Virtual Physiotherapy Group Intervention for Chronic Cough (ViP-Cough) achieved 80% uptake, with patients who received this intervention showing significant reductions in cough severity, cough ...

They’ve been hailed as miracle drugs, helping millions shed stubborn pounds and cutting the risk of heart attack and stroke by around 20 per cent. But as the use of GLP-1 weight-loss jabs has soared, ...

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough First pivotal trial is on track to initiate in the second quarter of ...

Specialists are more likely than primary care providers to view chronic cough as sensory neuropathy and prescribe neuromodulators for treatment. A clinician’s specialty, degree, and personal risk ...

Bruce D. Levy, MD, will become executive vice chancellor for medical affairs and dean of Washington University School of ...

Ignoring a chronic cough can lead to numerous complications. In particular, chronic coughing can result in pain in your ...